FDA approves first-in-class drug for polycythemia vera

1 month ago 6
The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) arsenic a caller attraction for adults with polycythemia vera who person not achieved capable power with existing therapies.
Read Entire Article